Feed Preview

Molecular diagnostic strategies in prion disease

Molecular diagnostic strategies in prion disease diagram by Jensflorian, Wikimedia
Jensflorian, Wikimedia

Prion diseases are fatal neurodegenerative and infectious disorders characterized by structural transition of the host-encoded cellular prion protein into the aberrantly folded pathologic isoform of the protein. Here is the latest research on molecular diagnostic strategies for prion diseases.

Top 20 most recent papers
Molecular Neurodegeneration

Dural lymphatics regulate clearance of extracellular tau from the CNS

Molecular NeurodegenerationMarch 1, 2019
Tirth K PatelDavid M Holtzman
31
1
2
64
PloS One

Intra-host and intra-household diversity of influenza A viruses during household transmissions in the 2013 season in 2 peri-urban communities of South Africa

PloS OneMay 26, 2018
Ziyaad Valley-OmarFlorette K Treurnicht
2
12
Handbook of Clinical Neurology

Public health: surveillance, infection prevention, and control

Handbook of Clinical NeurologyJune 12, 2018
Hester WardKaty Sinka
bioRxiv

Transmission of prion infectivity from blood by peptoid-conjugated beads

bioRxivApril 15, 2019
Simone HornemannAdriano Aguzzi
Methods in Molecular Biology

Study of Amyloids Using Yeast

Methods in Molecular BiologyJune 11, 2018
Reed B WicknerHerman K Edskes
International Psychogeriatrics

The most problematic symptoms of prion disease - an analysis of carer experiences

International PsychogeriatricsOctober 26, 2018
Liz FordSimon Mead
5
11
Viruses

The 19th Rocky Mountain Virology Association Meeting

VirusesJanuary 17, 2020
Joel RovnakRandall J Cohrs
NeuroImage. Clinical

Prion disease diagnosis using subject-specific imaging biomarkers within a multi-kernel Gaussian process

NeuroImage. ClinicalNovember 18, 2019
Liane S CanasMarc Modat
5
1
1
Methods in Molecular Biology

Bioluminescence Imaging of Neuroinflammation in a Mouse Model of Parkinson's Disease

Methods in Molecular BiologyNovember 14, 2019
Maria Eugenia Bernis, Gültekin Tamgüney
1
Langmuir : the ACS Journal of Surfaces and Colloids

Graphene Oxide Quantum Dot Alters Amyloidogenicity of Hen Egg White Lysozyme via Modulation of Protein Surface Character

Langmuir : the ACS Journal of Surfaces and ColloidsNovember 24, 2018
Deependra Kumar BanSubhankar Paul
1
8
The Lancet. Haematology

Assessment of ASC specks as a putative biomarker of pyroptosis in myelodysplastic syndromes: an observational cohort study

The Lancet. HaematologyAugust 4, 2018
Ashley A BasiorkaAlan F List
3
1
20
Neuropsychiatric Disease and Treatment

Characterization of mutations in PRNP (prion) gene and their possible roles in neurodegenerative diseases

Neuropsychiatric Disease and TreatmentAugust 28, 2018
Eva BagyinszkySangYun Kim
2
1
1
46
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Human prion diseases: current issues

Zhurnal nevrologii i psikhiatrii imeni S.S. KorsakovaJuly 25, 2018
N N ZavadenkoE N Saverskaya
1
Curēus

Imaging Manifestations of Creutzfeldt-Jakob Disease and Case Series

CurēusFebruary 26, 2019
David R WardenSteven A Messina
1
3
Handbook of Clinical Neurology

Iatrogenic Creutzfeldt-Jakob disease

Handbook of Clinical NeurologyJune 12, 2018
Atsushi KobayashiHidehiro Mizusawa
BMC Chemistry

Examination of paraben release from baby teethers through migration tests and GC-MS analysis using a stable isotope dilution assay

BMC ChemistryAugust 7, 2019
Theodoros PotouridisWilhelm Püttmann
3
2
Neurology. Clinical Practice

Variably protease-sensitive prionopathy: A differential diagnostic consideration for dementia

Neurology. Clinical PracticeMay 2, 2019
Stella H KimAdriana M Strutt
4
1
2
Nature Communications

Early preclinical detection of prions in the skin of prion-infected animals

Nature CommunicationsJanuary 18, 2019
Zerui WangWen-Quan Zou
17
8
21
Primary Care

Central Nervous System Infections

Primary CareAugust 18, 2018
Richard A Giovane, Paul Drake Lavender
Molecular Neurobiology

Inhibition of Autophagy by Captopril Attenuates Prion Peptide-Mediated Neuronal Apoptosis via AMPK Activation

Molecular NeurobiologyOctober 6, 2018
Ji-Hong MoonSang-Youel Park
2
5

See more papers from this feed

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/molecular-diagnostic-strategies-in-prion/ef69aa0e-036b-4e7b-8880-6bb4ec200bcd